Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 5Breast 4Genitourinary 2Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Prostatic Neoplasms 2

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lovastatin × Genitourinary × Clear all
NCT01478828 2019-03-27

Pre-Prostatectomy Lovastatin on Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Terminated
2 enrolled 4 charts
Genitourinary

Prostatic Neoplasms

NCT00580970 2016-11-18

Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury

Virginia Commonwealth University

Phase 2 Completed
73 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡